Temasek Holdings

Temasek Holdings, established in 1974 and based in Singapore, is an investment company managing a diversified portfolio valued at approximately S$242 billion. The firm actively invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, and energy. Temasek focuses on long-term investment themes such as transforming economies, growing middle-income populations, deepening comparative advantages, and supporting emerging champions. Its investment strategy encompasses a combination of liquid assets, listed and unlisted equities, and private equity opportunities, with a notable emphasis on mid-stage technology and life sciences investments through its private equity arm, Temasek Capital Management. Furthermore, Temasek aims to be the preferred investor for companies in Singapore and internationally, reflecting its commitment to global investment opportunities.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Eric Bielke

Director

Wendy Chandra

Managing Director, Technology

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Promit Ghosh

Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Sheau Ming Lim

Director

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Jonathan Popper

Managing Director, Portfolio Development Group

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Rohit Sobti

Managing Director, New Energy and Industrials

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Alan Thompson

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Ye Xu

Managing Director, Investment (China)

Past deals in Biofuel

Amogy

Series B in 2023
Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Living Carbon

Series A in 2023
Living Carbon, using biotechnology develop trees that better capture and store carbon. It also provides solutions for climate changes. It produces more durable wood for building and manufacturing applications. The company was founded in 2019 and is based in San Francisco, California.

InnovaFeed

Series D in 2022
InnovaFeed SAS is a biotech company based in Evry, France, that specializes in producing insect-based meal and oil primarily for the aquaculture industry. Founded in 2015, the company rears Hermetia illucens, commonly known as black soldier flies, to create innovative products such as ProtiNova, a protein source; SaniNova, a natural oil; and FertiNova, nutrient-rich insect droppings. InnovaFeed's approach integrates insect rearing into the agri-food system, focusing on nutrient recycling to provide sustainable feed for fish, birds, and small mammals. As global demand for protein rises, InnovaFeed's operations aim to contribute to a more sustainable food system while supporting the development of high-quality aquaculture practices.

BRUSA HyPower

Corporate Round in 2022
BRUSA HyPower is an energy conversion company focused on producing power technologies for electromobility. They manufacture a range of products including batteries, fuel cells, direct current converters, and onboard charging systems. These offerings are designed to support the transformation of electric vehicles for both on-highway and off-highway applications. By developing e-mobility systems suitable for everyday use, BRUSA HyPower aims to enhance the adoption of electric vehicles, contributing to long-term environmental and societal benefits. Their commitment to an ambitious environmental strategy underscores their role in promoting sustainable energy solutions.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

Pivot Bio

Series D in 2021
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

InnovaFeed

Venture Round in 2020
InnovaFeed SAS is a biotech company based in Evry, France, that specializes in producing insect-based meal and oil primarily for the aquaculture industry. Founded in 2015, the company rears Hermetia illucens, commonly known as black soldier flies, to create innovative products such as ProtiNova, a protein source; SaniNova, a natural oil; and FertiNova, nutrient-rich insect droppings. InnovaFeed's approach integrates insect rearing into the agri-food system, focusing on nutrient recycling to provide sustainable feed for fish, birds, and small mammals. As global demand for protein rises, InnovaFeed's operations aim to contribute to a more sustainable food system while supporting the development of high-quality aquaculture practices.

Pivot Bio

Series C in 2020
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Pivot Bio

Series B in 2018
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Boortmalt

Private Equity Round in 2017
Boortmalt produces and sells barley malts for breweries and distilleries around the world as well as for micro-breweries and distilleries.

Calysta

Series D in 2017
Calysta, Inc. is a biotechnology company focused on developing and manufacturing protein ingredients derived from sustainable sources. Based in Menlo Park, California, with additional locations in Houston, London, Stavanger, and Singapore, Calysta provides nutritional feeds and health products for fish and livestock, as well as chemicals used in various end products such as fibers, plastics, and building materials. The company also produces biofuels through innovative processes utilizing methane as a feedstock. Founded in 2011, Calysta was previously known as Calysta Energy before rebranding in 2014. Its technologies, including biological gas-to-liquids and gas-to-chemicals processes, aim to address global food security and meet the rising demand for sustainable protein in the aquaculture industry. The company has formed a strategic partnership with Bluestar Adisseo Company to enhance its market offerings.

Amyris

Post in 2015
Amyris, Inc. is a biotechnology company based in Emeryville, California, founded in 2003. The company specializes in developing technology that creates microbial strains for the production of various high-value ingredients derived from renewable plant-sourced sugars. Its innovative platform enables the engineering of microbes to convert these sugars into products for the clean health and beauty, flavor and fragrance, and industrial markets, including cosmetics, solvents, lubricants, and fuels. Amyris operates under several brands, such as Biossance and Purecane, and is involved in biopharmaceutical drug discovery and production. Additionally, the company collaborates with the Infectious Disease Research Institute to advance vaccine development, including efforts related to COVID-19. Revenue is generated through the sale of renewable products, licensing of intellectual property, and collaborative research and development services.

Amyris

Post in 2012
Amyris, Inc. is a biotechnology company based in Emeryville, California, founded in 2003. The company specializes in developing technology that creates microbial strains for the production of various high-value ingredients derived from renewable plant-sourced sugars. Its innovative platform enables the engineering of microbes to convert these sugars into products for the clean health and beauty, flavor and fragrance, and industrial markets, including cosmetics, solvents, lubricants, and fuels. Amyris operates under several brands, such as Biossance and Purecane, and is involved in biopharmaceutical drug discovery and production. Additionally, the company collaborates with the Infectious Disease Research Institute to advance vaccine development, including efforts related to COVID-19. Revenue is generated through the sale of renewable products, licensing of intellectual property, and collaborative research and development services.

Amyris

Post in 2012
Amyris, Inc. is a biotechnology company based in Emeryville, California, founded in 2003. The company specializes in developing technology that creates microbial strains for the production of various high-value ingredients derived from renewable plant-sourced sugars. Its innovative platform enables the engineering of microbes to convert these sugars into products for the clean health and beauty, flavor and fragrance, and industrial markets, including cosmetics, solvents, lubricants, and fuels. Amyris operates under several brands, such as Biossance and Purecane, and is involved in biopharmaceutical drug discovery and production. Additionally, the company collaborates with the Infectious Disease Research Institute to advance vaccine development, including efforts related to COVID-19. Revenue is generated through the sale of renewable products, licensing of intellectual property, and collaborative research and development services.

Amyris

Series D in 2010
Amyris, Inc. is a biotechnology company based in Emeryville, California, founded in 2003. The company specializes in developing technology that creates microbial strains for the production of various high-value ingredients derived from renewable plant-sourced sugars. Its innovative platform enables the engineering of microbes to convert these sugars into products for the clean health and beauty, flavor and fragrance, and industrial markets, including cosmetics, solvents, lubricants, and fuels. Amyris operates under several brands, such as Biossance and Purecane, and is involved in biopharmaceutical drug discovery and production. Additionally, the company collaborates with the Infectious Disease Research Institute to advance vaccine development, including efforts related to COVID-19. Revenue is generated through the sale of renewable products, licensing of intellectual property, and collaborative research and development services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.